| Trial Identifier: | D5670C00025 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT04091373 |
| Start Date: | September 2019 |
| Primary Completion Date: | March 2020 |
| Study Completion Date: | March 2020 |
| Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English version |
| Country | Location |
|---|---|
| United States of America, FL | Daytona Beach, FL, United States of America, 32117 |